← All diseases
Cancer
Bile duct cancer
Would you like to receive a message when there is new research on cholangiocarcinoma? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, a one-sentence summary explaining what was studied appears above each publication — and you'll be notified as soon as new research on Cholangiocarcinoma is published. View what Premium costs.
Publications and studies (2071)
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Construction and validation of a novel tumor morphology immune inflammatory nutritional score (TIIN score) for intrahepatic cholangiocarcinoma: a multicenter study. (2024/05/23) ♡
- The Clinical Association Between the Inflammation-Nutritional Condition and Prognosis of Locally Advanced Intrahepatic Cholangiocarcinoma After R0 Resection: Evidence from Competing Risk and Propensity Matching Analysis. (2024/05/07) ♡
- Neuroendocrine Tumours of Extrahepatic Biliary Tract: Report of Four Cases with Literature Review. (2024/05/01) ♡
- Osteosarcopenia is a significant predictor of recurrence and the prognosis after resection for extrahepatic bile duct cancer. (2024/05/01) ♡
- Revisiting the Malignant Masquerade at the Liver Hilum: Have We Made Progress? (2024/05/01) ♡
- Cannabidiol suppresses proliferation and induces cell death, autophagy and senescence in human cholangiocarcinoma cells via the PI3K/AKT/mTOR pathway. (2024/04/17) ♡
- Indications and outcomes of liver transplantation for liver tumors in the United States. (2024/04/04) ♡
- Impact of the course of the segment 4 hepatic artery on proximal ductal margin status in right hepatectomy for perihilar cholangiocarcinoma. (2024/04/01) ♡
- Utility of modified pancreaticoduodenectomy (Hi-cut PD) for middle-third cholangiocarcinoma: an alternative to hepatopancreaticoduodenectomy. (2024/04/01) ♡
- Integrated study reveals mechanism of Tripterygium Wilfordii against cholangiocarcinoma based on bioinformatics approaches and molecular dynamics simulation. (2024/04/01) ♡
- Selective internal radiation therapy using yttrium-90 microspheres for treatment of localized and locally advanced intrahepatic cholangiocarcinoma. (2024/04/01) ♡
- Autologous liver transplantation for unresectable hepatobiliary malignancies in enhanced recovery after surgery model. (2024/04/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The Impact of Radiofrequency Ablation on Survival Outcomes and Stent Patency in Patients with Unresectable Cholangiocarcinoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. (2024/03/30) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Treatment of cholangiocarcinoma in patients with primary sclerosing cholangitis: a comprehensive review. (2024/03/29) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. National guidelines for the diagnosis and treatment of hilar cholangiocarcinoma. (2024/03/07) ♡
- Surgical Resection Alone is Associated With Higher Long-Term Survival Than Multiagent Chemotherapy Alone for Patients With Localized Biliary Tract Cancers. (2024/03/01) ♡
- Single center experience using stereotactic body radiation therapy (SBRT) on orthotopic liver transplant protocol for unresectable cholangiocarcinoma. (2024/03/01) ♡
- Ultrasound findings of hepatic epithelioid hemangioendothelioma: comparison with other malignant hepatic tumors. (2024/03/01) ♡
- Current level of shared decision-making in hepatobiliary surgical oncology (SAPACHA). (2024/03/01) ♡
- The Global Burden of Early-Onset Biliary Tract Cancer: Insight From the Global Burden of Disease Study 2019. (2024/03/01) ♡
- Skeletal muscle status and survival among patients with advanced biliary tract cancer. (2024/03/01) ♡
- Parenchymal-sparing anatomical hepatectomy based on portal ramification of the right anterior section: A prospective multicenter experience with short-term outcomes. (2024/02/29) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Update on the Diagnosis and Treatment of Combined Hepatocellular Cholangiocarcinoma. (2024/02/28) ♡
- Circulating Tumor DNA Profiling in Liver Transplant for Hepatocellular Carcinoma, Cholangiocarcinoma, and Colorectal Liver Metastases: A Programmatic Proof of Concept. (2024/02/25) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Does enhanced recovery after surgery programs improve clinical outcomes in liver cancer surgery? (2024/02/15) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Multimodal prehabilitation program in patients with resectable perihilar cholangiocarcinoma: keypoints for an implementation protocol and literature review. (2024/02/14) ♡
- The scaffold of neutrophil extracellular traps promotes CCA progression and modulates angiogenesis via ITGAV/NFκB. (2024/02/08) ♡
- Clinical Implications of Naples Prognostic Score for Patients with Resected Cholangiocarcinoma: A Real-World Experience. (2024/02/02) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Advances and considerations in the use of immunotherapies for primary hepato-biliary malignancies. (2024/02/01) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Is There Room for Liposomal Irinotecan in Biliary Tract Cancer? A Meta-analysis of Randomised Trials. (2024/02/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Preoperative Endoscopic Ultrasound-Guided Hepaticogastrostomy for Definite Biliary Drainage in Hilar Cholangiocarcinoma Laparoscopic Resection: A Hybrid Minimal-Invasive Technique. (2024/02/01) ♡
- Multiomics analysis reveals metabolic subtypes and identifies diacylglycerol kinase α (DGKA) as a potential therapeutic target for intrahepatic cholangiocarcinoma. (2024/02/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. A novel use of the comprehensive complication index in perihilar cholangiocarcinoma surgery. (2024/02/01) ♡
- NIPBL::NACC1 Fusion Hepatic Carcinoma. (2024/02/01) ♡
- Reappraisal of a Renovated Cell-free and Concentrated Ascites Reinfusion Therapy for Malignant Ascites. (2024/02/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Molecular pathology for cholangiocarcinoma: a review of actionable genetic targets and their relevance to adjuvant & neoadjuvant therapy, staging, follow-up, and determination of minimal residual disease. (2024/02/01) ♡
- Fruit and Vegetable Consumption Promotion Model and Prevention for Cholangiocarcinoma: A Direct Hit to the Target? (2024/02/01) ♡
- Prognostic value of preoperative geriatric nutritional risk index in intrahepatic cholangiocarcinoma after hepatectomy: a single‑center retrospective cohort study. (2024/01/25) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Liver-Directed Therapy Combined with Systemic Therapy: Current Status and Future Directions. (2024/01/24) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case report: Pemigatinib-induced retinopathy: a serial examination of subretinal fluid secondary to an FGFR inhibitor. (2024/01/22) ♡
- Safety and efficacy of biliary stenting combined with iodine-125 seed strand followed by hepatic artery infusion chemotherapy plus lenvatinib with PD-1 inhibitor for the treatment of extrahepatic cholangiocarcinoma with malignant obstructive jaundice. (2024/01/15) ♡
- Retracted publicationiThis research has been withdrawn by science itself, for example due to a flaw in the method or unreliable data. Do not use it as support and do not discuss it as evidence. Dual-phenotype hepatocellular carcinoma: correlation of MRI features with other primary hepatocellular carcinoma and differential diagnosis. (2024/01/11) ♡
- Histopathological Spectrum and Molecular Characterization of Liver Tumors in the Setting of Fontan-Associated Liver Disease. (2024/01/11) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The role of extracellular vesicles in cholangiocarcinoma tumor microenvironment. (2024/01/10) ♡
- Dissecting cellular heterogeneity and intercellular communication in cholangiocarcinoma: implications for individualized therapeutic strategies. (2024/01/04) ♡
- Downregulation of JAM3 occurs in cholangiocarcinoma by hypermethylation: A potential molecular marker for diagnosis and prognosis. (2024/01/01) ♡
- Underrepresentation of Hispanics in clinical trials for liver cancer in the United States over the past 20 years. (2024/01/01) ♡
- Nestin may be a candidate marker for differential diagnosis between small duct type and large duct type intrahepatic cholangiocarcinomas. (2024/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Germline Genetic Associations for Hepatobiliary Cancers. (2024/01/01) ♡
- APRI score is not predictive of post-surgical outcomes in cholangiocarcinoma patients. (2024/01/01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.